Insider · CIK 0001406338

Sachdev Amit

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001406338

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-21	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+8,251 sh	—	—	66,512
2026-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−1,846 sh	$486.35	−$898K	55,570
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−1,518 sh	$485.11	−$736K	57,416
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP Chief Patient & Ext Af Off	MExercise/Conversion	+23.5K sh	$155.57	+$3.65M	92,521
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP Chief Patient & Ext Af Off	MExercise/Conversion	+25K sh	$187.53	+$4.69M	117,547
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−920 sh	$463.91	−$427K	116,627
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−2,730 sh	$465.05	−$1.27M	113,897
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−1,848 sh	$465.80	−$861K	112,049
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−10.3K sh	$467.75	−$4.8M	101,786
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−19.7K sh	$468.57	−$9.21M	82,124
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−7,241 sh	$469.61	−$3.4M	74,883
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−11.7K sh	$470.54	−$5.51M	63,171
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−4,237 sh	$471.43	−$2M	58,934
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	EVP Chief Patient & Ext Af Off	MExercise/Conversion	−23.5K sh	—	—	0
2026-02-19	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	EVP Chief Patient & Ext Af Off	MExercise/Conversion	−25K sh	—	—	0
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+5,789 sh	—	—	71,182
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,140 sh	$483.75	−$1.04M	69,042
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−3,548 sh	$487.76	−$1.73M	65,393
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,057 sh	$468.41	−$964K	68,941
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+7,866 sh	—	—	67,115
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+3,883 sh	—	—	70,998
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−3,703 sh	$479.61	−$1.78M	68,490
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,470 sh	$483.28	−$1.19M	72,193
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,139 sh	$463.46	−$991K	74,663
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+6,211 sh	—	—	76,802
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,056 sh	$467.98	−$962K	70,591
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+8,210 sh	—	—	65,533
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+7,114 sh	—	—	72,647
2024-06-05	VRTXVERTEX PHARMACEUTICALS INC / MAG Gift	EVP Chief Patient & Ext Af Off	GGift	−4,600 sh	—	—	0
2024-05-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−32 sh	$430.93	−$13.8K	55,325
2024-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−3,004 sh	$425.70	−$1.28M	55,325
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,469 sh	$431.79	−$1.07M	58,329
2024-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−3,191 sh	$421.77	−$1.35M	60,798
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,623 sh	$420.58	−$1.1M	68,243
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−4,254 sh	$420.79	−$1.79M	63,989
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−3,498 sh	$424.01	−$1.48M	70,866
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−3,222 sh	$420.24	−$1.35M	74,364
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,022 sh	$422.74	−$855K	77,586
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+7,114 sh	—	—	79,608
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+5,814 sh	—	—	64,628
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+7,866 sh	—	—	72,494
2023-11-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−35 sh	$369.92	−$12.9K	58,814
2023-08-10	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP Chief Patient & Ext Af Off	SSale	−10K sh	$350.00	−$3.51M	58,814
2023-03-01	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2023-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,468 sh	$289.12	−$714K	66,518
2023-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−3,498 sh	$292.85	−$1.02M	68,986
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−4,657 sh	$298.26	−$1.39M	72,484
2023-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP Chief Patient & Ext Af Off	FTax Payment	−2,611 sh	$294.33	−$768K	77,141
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+10.3K sh	—	—	63,676
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP Chief Patient & Ext Af Off	AAward	+8,210 sh	—	—	71,886

Recent filings

Accepted (ET)
Jul 234
Sachdev Amit0000875320-26-000251
SEC(opens sec.gov)
Feb 264
Sachdev Amit0000875320-26-000118
SEC(opens sec.gov)
Feb 234
Sachdev Amit0000875320-26-000102
SEC(opens sec.gov)
Feb 194
Sachdev Amit0000875320-26-000096
SEC(opens sec.gov)
Feb 184
Sachdev Amit0000875320-26-000074
SEC(opens sec.gov)
Feb 124
Sachdev Amit0000875320-26-000050
SEC(opens sec.gov)
Jan 264
Sachdev Amit0000875320-26-000024
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210